In vitro genotoxicity testing–Can the performance be enhanced?

Food and Chemical Toxicology

Volumn 106, Issue , 2017, Pages 600-608

  Corvi, Raffaella ^a   Madia, Federica ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Alternative methods; Genotoxicity; In vitro mammalian cell test; Safety assessment

Indexed keywords

ACCURACY; AMES TEST; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CHROMOSOME DAMAGE; CYTOTOXICITY TEST; DNA DAMAGE; GENE MUTATION; GENOTOXICITY; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; MICRONUCLEUS TEST; NONHUMAN; NUMERICAL CHROMOSOME ABERRATION; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING; VALIDITY; ANIMAL; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; MUTAGEN TESTING; PROCEDURES; STANDARDS;

DNA; MUTAGENIC AGENT;

ANIMALS; DNA; DNA DAMAGE; HUMANS; MUTAGENICITY TESTS; MUTAGENS;

EID: 84994516231     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.08.024     Document Type: Article

References (57)

1. Aardema, M.J., Barnett, B.C., Khambatta, Z., Reisinger, K., Ouedraogo-Arras, G., Faquet, B., Ginestet, A.C., Mun, G.C., Dahl, E.L., Hewitt, N.J., Corvi, R., Curren, R.D., International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. Mutat. Res. 701 (2010), 123–131, 10.1016/j.mrgentox.2010.05.017.
2. Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K.E., Angers-Loustau, A., Aptula, A., Bal-Price, A., Benfenati, E., Bernauer, U., Bessems, J., Bois, F.Y., Boobis, A., Brandon, E., Bremer, S., Broschard, T., Casati, S., Coecke, S., Corvi, R., Cronin, M., Daston, G., Dekant, W., Felter, S., Grignard, E., Gundert-Remy, U., Heinonen, T., Kimber, I., Kleinjans, J., Komulainen, H., Kreiling, R., Kreysa, J., Leite, S.B., Loizou, G., Maxwell, G., Mazzatorta, P., Munn, S., Pfuhler, S., Phrakonkham, P., Piersma, A., Poth, A., Prieto, P., Repetto, G., Rogiers, V., Schoeters, G., Schwarz, M., Serafimova, R., Tähti, H., Testai, E., van Delft, J., van Loveren, H., Vinken, M., Worth, A., Zaldivar, J.M., Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 85:5 (2011), 367–485, 10.1007/s00204-011-0693-2.
3. Berndt-Weis, M.L., Kauri, L.M., Williams, A., White, P., Douglas, G., Yauk, C., Global transcriptional characterization of a mouse pulmonary epithelial cell line for use in genetic toxicology. Toxicol. In Vitro 23:5 (2009), 816–833, 10.1016/j.tiv.2009.04.008.
4. Birrell, L., Cahill, P., Hughes, C., Tate, M., Walmsley, R.M., GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Mutat. Res. 695 (2010), 87–95, 10.1016/j.mrgentox.2009.12.008.
5. Bourdon-Lacombe, J.A., Moffat, I.D., Deveau, M., Husain, M., Auerbach, S., Krewski, D., Thomas, R.S., Bushel, P.R., Williams, A., Yauk, C.L., Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals. Toxicol. Appl. Pharmacol. 289:3 (2015), 573–588, 10.1016/j.yrtph.2015.04.010.
6. Bowen, D.E., Whitwell, J.W., Lillfordm, L., Hnederson, D., Kidd, D., Mc Garry, S., Pearce, G., Beevers, C., Kirkland, D.J., Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat. Res. 722:1 (2011), 7–19, 10.1016/j.mrgentox.2011.02.00.
7. Bryce, S., Bernacki, D.T., Bemis, J.C., Dertinger, S.D., Genotoxic mode of ation predictions from a multiplexed flow cytometry assay and a machine learning approach. Environ. Mol. Mutat. 57 (2016), 171–189, 10.1002/em.21996.
8. Buick, J.K., Moffat, I., Williams, A., Swartz, C.D., Recio, L., Hyduke, D.R., Li, H.H., Fornace, A.J. Jr., Aubrecht, J., Yauk, C.L., Integration of metabolic activation with a predictive toxicogenomics signature to classify genotoxic versus non genotoxic chemicals in human TK6 cells. Environ. Mol. Mutagen 56 (2015), 520–534, 10.1002/em.21940.
9. COM, Guidance on a strategy for testing of chemicals for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM), 2011, Department of Health, London http://www.iacom.org.uk/guidstate/documents/COMGuidanceFINAL2.pdf].
10. Doktorova, T.Y., Ates, G., Vinken, M., Vanhaecke, T., Rogiers, V., Way forward in case of a false positive in vitro genotoxicity result for a cosmetic substance?. Toxicol. In Vitro 28:1 (2014), 54–59, 10.1016/j.tiv.2013.09.022.
11. EC, Regulation No 1907/2006 of the European Parliament and the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency, amending Directive 1999/45/EC and Repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396 of 30122006. 2006, 1–849.
12. EC, Regulation No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. 2008, 1–1355 OJ L 353 of 16122008.
13. EC, Regulation No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products (Text with EEA Relevance). 2009 OJ L 342 of 22122009.
14. EC, Regulation No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. 2009, 1–50 OJ L 309 of 24112009.
15. ECVAM, EURL ECVAM Strategy to Avoid and Reduce Animal use in Genotoxicity Testing. (2013) JRC Scientific and Policy Report., 2013, 10.2788/43865.
16. EFSA, Scientific opinion of the scientific committee on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA J., 9(9), 2011, 69, 10.2903/j.efsa.2011.2379 2011.
17. EU, Regulation No 528/2012 of the European Parliament and of the Council of 22 May 2012 Concerning the Making Available on the Market and Use of Biocidal Products (Text with EEA Relevance). 2012, 1–123 OJ L 167 of 22052012.
18. EU, Commission Regulation No 283/2013 Setting Out the Data Requirements for Active Substances, in Accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council Concerning the Placing of Plant Protection Products on the Market. 2013, 1–84 OJ L 93 of 01032013.
19. EU, Commission Regulation No 284/2013 Setting Out the Data Requirements for Plant Protection Products, in Accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council Concerning the Placing of Plant Protection Products on the Market (Text with EEA Relevance). 2013, 85–152 OJ L 93 of 01032013.
20. Fowler, P., Smith, R., Young, J., Jeffrey, L., Kirkland, D., Pfuhler, S., Carmichael, P., Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. choice of cell type. Mutat. Res. 742 (2012), 11–25, 10.1016/j.mrgentox.2011.10.014.
21. Fowler, P., Smith, R., Smith, K., Young, J., Jeffrey, L., Kirkland, D., Pfuhler, S., Carmichael, P., Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurement. Mutat. Res. 747 (2012), 104–117, 10.1016/j.mrgentox.2012.04.013.
22. Garcia-Canton, C., Anadon, A., Meredith, C., Assessment of the in vitro H2AX assay by high content screening as a novel genotoxicity test. Mutat. Res. 757 (2013), 158–166, 10.1016/j.toxlet.2013.08.024.
23. Greywe, D., Kreutz, J., Banduhn, N., Krauledat, M., Scheel, J., Schroeder, K.R., Wolf, T., Reisinger, K., Applicability and robustness of the hen's egg test for analysis of micronucleus induction (HET-MN): results from an inter-laboratory trial. Mutat. Res. 747 (2012), 118–134, 10.1016/j.mrgentox.2012.04.012.
24. Hastwell, P.W., Chai, L.L., Roberts, K.J., Webster, T.W., Harvey, J.S., Rees, R.W., Walmsley, R.M., High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the greenscreen HC GADD45a-GFP genotoxicity assay. Mutat. Res. 607 (2006), 160–175, 10.1016/j.mrgentox.2006.04.011.
25. Hastwell, P.W., Webster, T.W., Tate, M., Billinton, N., Lynch, A.M., Harvey, J.S., Rees, R.W., Walmsley, R.M., Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'greenscreen HC' genotoxicity assay. Mutagenesis 24 (2009), 455–463, 10.1093/mutage/gep029.
26. Hendriks, G., Derr, R.S., Misovic, B., Morolli, B., Calléja, F.M., Vrieling, H., The extended ToxTracker assay discriminates between induction of DNA damage, oxidative stress, and protein misfolding. Toxicol. Sci. 150:1 (2016), 190–203, 10.1093/toxsci/kfv323.
27. Hu, T., Khambatta, Z.S., Hayden, P.J., Bolmarcich, J., Binder, R.L., Robinson, M.K., Carr, G.J., Tiesman, J.P., Jarrold, B.B., Osborne, R., Reichling, T.D., Nemeth, S.T., Aardema, M.J., Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol. In. Vitro 24:5 (2010), 1450–1463, 10.1016/j.tiv.2010.03.013.
28. ICH S2(R1), ICH Guideline S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. 2011, 1–28 EMA/CHMP/ICH/126642/2008, rev June 2012.
29. Jagger, C., Tate, M., Cahill, P.A., Hughes, C., Knight, A.W., Billinton, N., Walmsley, R.M., Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. Mutagenesis 24:1 (2009), 35–50, 10.1093/mutage/gen050.
30. Khoury, L., Zalko, D., Audebert, M., Validation of high-throughput genotoxicity assay screening using γH2AX in-cell western assay on HepG2 cells. Environ. Mol. Mutagen. 54 (2013), 737–746, 10.1093/mutage/gev058.
31. Kirkland, D., Aardema, M., Henderson, L., Müller, L., Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. sensitivity, specificity and relative predictivity. Mutat. Res. 584 (2005), 1–256, 10.1016/j.mrgentox.2005.02.004.
32. Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H.-R., Hastwell, P., Hayashi, M., Kasper, P., Kirchner, S., Lynch, A., Marzin, D., Maurici, D., Meunier, J.-R., Mueller, L., Nohynek, G., Parry, J., Parry, E., Thybaud, V., Tice, R., van Benthem, J., Vanparys, P., White, P., How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow up animal tests: report of an ECVAM workshop. Mutat. Res. 628 (2007), 31–55, 10.1016/j.mrgentox.2006.11.008.
33. Kirkland, D., Kasper, P., Mueller, L., Corvi, R., Speit, G., Recommended lists ofgenotoxic and non-genotoxic chemicals for assessment of the performanceof new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat. Res. 653 (2008), 99–108, 10.1016/j.mrgentox.2008.03.008.
34. Kirkland, D., Fowler, P., Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern. Mutagenesis 25:6 (2010), 539–553, 10.1093/mutage/geq041.
35. Kirkland, D., Reeve, L., Gatehouse, D., Vanparys, P., A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat. Res. 721 (2011), 27–73, 10.1016/j.mrgentox.2010.12.015.
36. Kirkland, D., Zeiger, E., Madia, F., Gooderham, N., Kasper, P., Lynch, A., Morita, T., Ouedraogo, G., Parra Morte, J.M., Pfuhler, S., Rogiers, V., Schulz, M., Thybaud, V., van Benthem, J., Vanparys, P., Worth, A., Corvi, R., Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. reports of individual databases presented at an EURL ECVAM workshop. Mutat. Res. 775–776 (2014), 55–68, 10.1016/j.mrgentox.2014.10.005.
37. Kirkland, D., Zeiger, E., Madia, F., Corvi, R., Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? II. construction and analysis of a consolidated database. Mutat. Res. 775–776 (2014), 69–80, 10.1016/j.mrgentox.2014.10.006.
38. Kirkland, D., Kasper, P., Martus, H.-J., Mueller, L., van Benthem, J., Madia, F., Corvi, R., Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutat. Res. 795 (2016), 7–30, 10.1016/j.mrgentox.2015.10.006.
39. Li, H.H., Hyduke, D.R., Chen, R., Heard, P., Yauk, C.L., Aubrecht, J., Fornace, A.J. Jr., Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells. Environ. Mol. Mutagen. 56 (2015), 505–519, 10.1002/em.21941.
40. Luijten, M., Olthof, E.,D., Hakkert, B.,C., Rorije, E., van der Laan, J.-W., Woutersen, R.A., van Benthem, J., An integrative test strategy for cancer hazard identification. Cri. Rev. Toxicol. 46:7 (2016), 615–639, 10.3109/10408444.2016.1171294.
41. Moffat, I., Chepelev, N.L., Labib, S., Bourdon-Lacombe, J., Kuo, B., Buick, J.K., Lemieux, F., Williams, A., Halappanavar, S., Malik, A.I., Luijten, M., Aubrecht, J., Hyduke, D.R., Fornace, A.J. Jr., Swartz, C.D., Recio, L., Yauk, C.L., Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water. Crit. Rev. Toxicol. 45:1 (2015), 1–43, 10.3109/10408444.2014.973934.
42. OECD website, http://www.oecd.org/env/ehs/testing/oecdguidelinesforthetestingofchemicals.htm.
43. Parry, J.M., Parry, E., Phrakonkham, P., Corvi, R., Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing. Mutagenesis 25:6 (2010), 531–538, 10.1093/mutage/geq046.
44. Petkov, P.I., Schultz, T.W., Donner, E.M., Honma, M., Morita, T., Hamada, S., Wakata, A., Mishima, M., Maniwa, J., Todorov, M., Kaloyanova, E., Kotov, S., Mekenyan, O.G., Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity. J. Appl. Toxicol., 2016, 10.1002/jat.3338 May 25 [EPub ahead of Print].
45. Pfuhler, S., Kirkland, D., Kasper, P., Hayashi, M., Vanparys, P., Carmichael, P., Dertinger, S., Eastmond, D., Elhajouji, A., Krul, C., Rothfuss, A., Schoening, G., Smith, A., Speit, G., Thomas, C., van Benthem, J., Corvi, R., Reduction of use of animals in regulatory genotoxicity testing: identification and implementation opportunities - report from an ECVAM workshop. Mutat. Res. 680:1–2 (2009), 31–42, 10.1016/j.mrgentox.2009.09.002.
46. Pfuhler, S., Fellows, M., van Benthem, J., Corvi, R., Curren, R., Dearfield, K., Fowler, P., Frötschl, R., Elhajouji, A., Le Hégarat, L., Kasamatsu, T., Kojima, H., Ouédraogo, G., Scott, A., Speit, G., In vitro genotoxicity test approaches with better predictivity: summary of an IWGT workshop. Mutat. Res. 723 (2011), 101–107, 10.1016/j.mrgentox.2011.03.013.
47. Reflection Paper Providing an Overview of the Current 4 Regulatory Testing Requirements for Veterinary Medicinal 5 Products and Opportunities for Implementation of the 3Rs. Draft 21 April, 2016 EMA/CHMP/CVMP/JEG-3Rs/164002/2016.
48. Reus, A.A., Reisinger, K., Downs, T.R., Carr, G.J., Zeller, A., Corvi, R., Krul, C.A., Pfuhler, S., Comet assay in reconstructed 3D human epidermal skin models–investigation of intra- and inter-laboratory reproducibility with coded chemicals. Mutagenesis 28:6 (2013), 709–720, 10.1093/mutage/get051.
49. Rothfuss, A., O'Donovan, M., De Boeck, M., Brault, D., Czich, A., Custer, L., Hamada, S., Plappert-Helbig, U., Hayashi, M., Howe, J., Kraynak, A., van der Leede, B., Nakajima, M., Priestley, C., Thybaud, V., Saigo, K., Sawant, S., Shi, J., Storer, R., Struwe, M., Vock, E., Galloway, S., Collaborative study on 15 compounds in the rat liver Comet Assay integrated into 2- and 4-week repeat-dose studies. Mutat. Res. 702 (2010), 40–69, 10.1016/j.mrgentox.2010.07.006.
50. Rothfuss, A., Honma, M., Czich, A., Aardema, M.J., Burlinson, B., Galloway, S., Hamada, S., Kirkland, D., Heflich, R.H., Howe, J., Nakajima, M., O'Donovan, M., Plappert-Helbig, U., Priestley, C., Recio, L., Schuler, M., Uno, Y., Martus, H.-J., Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing. Mutat. Res. 723 (2011), 108–120, 10.1016/j.mrgentox.2010.12.005.
51. SCCS, SCCS's Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation. 2015 9th revision, 25 April 2016, SCCS/1564/15.
52. van der Linden, S.C., von Bergh, A.R.M., van Vught-Lussenburg, B.M.A., Jonker, L.R.A., Teunis, M., Krul, C.A.M., van der Burg, B., Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress. Mutat. Res. 760 (2014), 23–32, 10.1016/j.mrgentox.2013.09.009.
53. VICH GL23(R), VICH GL23: Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing. 6 November 2014 EMA/CVMP/VICH/526/2000. 2014, 1–10 Revision Step 9.
54. Westerink, W.M., Stevenson, J.C., Horbach, G.J., Schoonen, W.G., The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development. Mutat. Res. 696:1 (2010), 21–40, 10.1016/j.mrgentox.2009.12.007.
55. Wolf, T., Niehaus-Rolf, C., Banduhn, N., Eschrich, D., Scheel, J., Luepke, N.P., The hen's egg test for micronucleus induction (HET-MN): novel analyses with a series of well-characterized substances support the further evaluation of the test system. Mutat. Res. 650 (2008), 150–164, 10.1016/j.mrgentox.2007.11.009.
56. Zhang, L., McHale, C.M., Greene, N., Snyder, R.D., Rich, I.N., Aardema, M.J., Roy, S., Pfuhler, S., Venkatactahalam, S., Emerging approaches in predictive toxicology. Environ. Mol. Mutagen. 55:9 (2014), 679–688, 10.1002/em.21885.
57. Zwart, E.P., Schaap, M.M., van den Dungen, M.W., Braakhuis, H.M., White, P.A., van Steeg, H., van Benthem, J., Luijten, M., Proliferating primary hepatocytes from the pUR288 lacZ plasmid mouse are valuable tools for genotoxicity assessment in vitro. Environ. Mol. Mutagen. 53:5 (2012), 1–8, 10.1002/em.21700.